News Digest / Income Statements / Xenous Holdings Reports Increased Losses and Ongoing Financial Struggles in Q4 2024

Xenous Holdings Reports Increased Losses and Ongoing Financial Struggles in Q4 2024

Samuel Brooks
06:46am, Friday, Feb 14, 2025
Illustration by StockInvest.us

Xenous Holdings, Inc. (PINK: XITO) has released its quarterly report for the period ended December 31, 2024. The company continues to operate without generating any revenue and is facing ongoing financial challenges.

Positive Aspects:

  • The net loss for the most recent three-month period was slightly lower than in the previous year, indicating a minor improvement in cost management. For Q3 2024, the net loss was $14,894 compared to $14,923 for Q3 2023.
  • The company has successfully maintained its common stock count at 760,250,000 shares without any dilution during the nine-month period ending December 31, 2024.
  • The continuation of financial support from its majority shareholder, Smartex Investment Ltd., which provided advances of $49,057 in the current fiscal period.

Negative Aspects:

  • The total stockholders' deficit increased to $885,215 from $839,166 as of March 31, 2024, reflecting deteriorating financial health.
  • The accumulated deficit has risen to $1,196,015 by December 31, 2024, from $1,149,966, indicating ongoing operating losses.
  • Cash flow from operating activities remains negative, with $49,057 used in operations for the nine months ended December 31, 2024, compared to $40,168 in the prior year.
  • The company has not engaged in any business operation since inception, raising concerns about its viability as an ongoing concern if conditions do not improve.
  • A significant reliance on related-party transactions for funding further complicates the financial outlook.

Key Financial Highlights:

  • Net Loss (3 months ending December 31, 2024): $14,894
  • Net Loss (3 months ending December 31, 2023): $14,923
  • Total Liabilities (as of December 31, 2024): $885,215
  • Current Asset: $0
  • Accumulator Deficit (as of December 31, 2024): $1,196,015
  • Working Capital Deficiency (as of December 31, 2024): $885,215

The company is in a precarious position with ongoing threats to its operations and no clear path to profitability. Without substantive changes or new revenue streams, it may continue struggling with financial instability moving forward.

About The Author

Samuel Brooks

Trusted Broker
Start Your Journey With:
eToro
0% Commission Stock Trading
Follow Other Investors Strategy
Wide variety: Crypto, stocks, ETFs

Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk.